Worldwide Healthcare Trust PLC Edison issues review on Worldwide Healthcare Trust
July 26 2022 - 3:49AM
RNS Non-Regulatory
TIDMWWH
Worldwide Healthcare Trust PLC
26 July 2022
London, UK, 26 July 2022
Edison issues review on Worldwide Healthcare Trust (WWH)
Worldwide Healthcare Trust (WWH) has two co-managers, Sven Borho
and Trevor Polischuk at global healthcare specialist OrbiMed. Borho
recently presented at the WWH AGM and despite disappointing
performance in FY22 (March year-end), which he notes was a 'mirror
image' of FY21, the manager remains optimistic about the trust's
prospects. He is hopeful that May/June 2022 marked the low point in
the absolute and relative performance of biotech stocks and is
confident that the focus on favouring emerging biotech and emerging
market stocks over large-cap pharma companies will once again be
the correct strategy for WWH's shareholders. Borho considers that
the trust's portfolio offers investors a 'mix of the big guys',
which gives some stability, along with 'explosive growth'
companies, and this approach has delivered significant
outperformance versus WWH's benchmark over the long term.
WWH's shares are trading at a 6.9% discount to its cum-income
NAV, which is wider than the 0.3% to 3.3% range of average
discounts over the last one, three, five and 10 years. This may be
due to a period of meaningful underperformance versus the trust's
benchmark in FY22. WWH's board employs a discount-control
mechanism, aiming to ensure a maximum 6% share price discount to
ex-income NAV in normal market conditions.
Click here to view the full report or here to sign up to receive
research as it is published.
All reports published by Edison are available to download free
of charge from its website
www.edisongroup.com
About Edison: E dison is a leading research and investor
relations consultancy, connecting listed companies to the widest
pool of global investors. By focusing on the volume and quality of
investors reached - across institutions, family offices, wealth
managers and retail investors - Edison can create and gauge intent
to purchase, even in the darkest pools of capital, and then make
introductions via non-deal roadshows, events or virtual
meetings.
Having been the first in-market 17 years ago, Edison now has
more than 100 analysts covering every economic sector.
Headquartered in London, Edison also has offices in New York,
Frankfurt, Amsterdam and Tel Aviv and a presence in Athens,
Johannesburg and Sydney.
Edison is authorised and regulated by the Financial Conduct
Authority .
Edison is not an adviser or broker-dealer and does not provide
investment advice. Edison's reports are not solicitations to buy or
sell any securities.
For more information, please contact Edison:
Mel Jenner +44 (0)20 3077 5700
investmenttrusts@edisongroup.com
Learn more at www.edisongroup.com and connect with Edison
on:
LinkedIn www.linkedin.com/company/edison-group-/
Twitter www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRARFMRTMTITMPT
(END) Dow Jones Newswires
July 26, 2022 03:49 ET (07:49 GMT)
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Finsbury Worldwide Pharm (LSE:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024